» Articles » PMID: 32243797

Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 2020 Apr 4
PMID 32243797
Citations 128
Authors
Affiliations
Soon will be listed here.
Abstract

Autoimmune diseases are a result of the immune system being misdirected toward its host and have major and increasing unmet clinical needs. In general, present therapies are broadly acting and non-disease specific; consequently, they are associated with numerous side effects. Precise and early intervention strategies are urgently needed. We highlight the challenges, progress, and prospects in achieving these goals.

Citing Articles

Impact of FcRn antagonism on vaccine-induced protective immune responses against viral challenge in COVID-19 and influenza mouse vaccination models.

Warang P, Singh G, Moshir M, Binazon O, Laghlali G, Chang L Hum Vaccin Immunother. 2025; 21(1):2470542.

PMID: 40028815 PMC: 11881870. DOI: 10.1080/21645515.2025.2470542.


Mesenchymal Stromal Cell-Based Therapy: A Promising Approach for Autoimmune Diseases.

Li L, He Y, Zhao J, Yin H, Feng X, Fan X Clin Rev Allergy Immunol. 2025; 68(1):21.

PMID: 39982546 DOI: 10.1007/s12016-025-09030-9.


The effects of coagulation factors on the risk of autoimmune diseases: A Mendelian randomization study.

Li S, Zhou C, Li W, Kang L, Mu H Medicine (Baltimore). 2025; 103(52):e40893.

PMID: 39969330 PMC: 11688059. DOI: 10.1097/MD.0000000000040893.


Recent advancements in the chemistry of Diels-Alder reaction for total synthesis of natural products: a comprehensive review (2020-2023).

Rana A, Mishra A, Awasthi S RSC Adv. 2025; 15(6):4496-4525.

PMID: 39931410 PMC: 11808662. DOI: 10.1039/d4ra07989b.


Cellular therapies in rheumatic and musculoskeletal diseases.

Franco-Fuquen P, Figueroa-Aguirre J, Martinez D, Moreno-Cortes E, Garcia-Robledo J, Vargas-Cely F J Transl Autoimmun. 2025; 10:100264.

PMID: 39931050 PMC: 11808717. DOI: 10.1016/j.jtauto.2024.100264.